Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Syd n ey NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT Actinogen presents a brief corporate presentation highlighting the Company, Xanamem and its strong scientific rationale in...
ACW Bioshares presentation, strong cortisol rationale
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
In the deck
Earlier from Actinogen Medical
- Application for quotation of securities - ACW
- ACW webinar on the future of Alzheimers treatment
- June 2026 Quarterly activity report & Appendix 4C
- Xanamem depression trial published in British J Psychiatry
- ACW third positive XanaMIA trial data committee review
Later from Actinogen Medical
- Notification of cessation of securities - ACW
- Updated Securities Trading Policy
- ACW webinar today, The future of Alzheimers treatment
- Appendix 3Y-Malcolm McComas
- Appendix 3Y - Dr George Morstyn
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical